Skip to main content
SpringerLink
Log in

Herzinsuffizienz

  • Chapter
Repetitorium Intensivmedizin

  • 2747 Accesses

Zusammenfassung

ProBNP dient auch sehr gut zur Differenzierung bei akuter Dyspnoe (keine kardiale Ursache der Dyspnoe bei geringen ProBNP-Werten!).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Ausgewählte Literatur

  • Abraham WT, Fisher WG, Smith AL et al., for the MIRACLE Study Group (2002) Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1845–1853

    Article  PubMed  Google Scholar 

  • Anand IS, Fisher LD, Chiang YT et al., for the Val-HeFT Investigators (2003) Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 107:1278–1283

    Article  PubMed  CAS  Google Scholar 

  • Auricchio A et al. (1999) Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive heart failure Study Group. Circulation 99:2993–3001

    PubMed  CAS  Google Scholar 

  • Bristow MR, Saxon LA, Boehmer J et al., for the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350: 2140–2150

    Article  PubMed  CAS  Google Scholar 

  • Deutsche gesellschaft fur Kardiologie (2009) Pocket-Leitlinien »Therapie der chronischen Herzinsuffizienz

    Google Scholar 

  • Cazeau S, Leclercq C, Lavergne T et al. (2001) Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344:873–880

    Article  PubMed  CAS  Google Scholar 

  • Cohn JN, Tognoni GA, for the Valsartan Heart Failure Trial Investigators (2001) A randomized trial of the angiotensinreceptor blocker valsartan in chronic heart failure. N Engl J Med 346:1667–1675

    Article  Google Scholar 

  • Cowie MR, Mosterd A, Wood DA, Deckers JW, Poole-Wilson PA, Suuton GC, Grobbee DE (1997) The epidemiology of heart failure. Eur Heart J 18:208–225

    PubMed  CAS  Google Scholar 

  • Fuster V, Ryden LE, Cannom DS et al (2006) ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation). Eur Heart J 27:1979–2030

    Article  PubMed  Google Scholar 

  • Garg R, Yusuf S, for the Collaborative Group on ACE Inhibitor Trials (1995) Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 273:1450–1456

    Article  PubMed  CAS  Google Scholar 

  • Granger CB, McMurray JJ, Yusuf S et al. (2003) Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARMAlternative trial. Lancet 362:772–776

    Article  PubMed  CAS  Google Scholar 

  • Groban L, Butterworth J (2006) Perioperative Management of Chronic Heart Failure. Anesth Analg 103: 557–575

    Article  PubMed  Google Scholar 

  • Hohnloser SH et al. (2000) Leitlinien zur Implantation von Defibrillatoren. Z Kardiol 89:126–135

    Article  Google Scholar 

  • Hoppe UC, Böhm M, Dietz R et al (2005) Leitlinien zur Therapie der chronischen Herzinsuffizienz. Im Auftrag der Deutschen Gesellschaft für Kardiologie. Z Kardiol 94: 488–509

    Article  PubMed  CAS  Google Scholar 

  • Hoppe UC, Böhm M, Drexler H et al. (2009) Kommentar zu den ESC-Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008. Kardiologe 3: 16–23

    Article  Google Scholar 

  • Hoppe UC, Erdmann E (2002) Chronische Herzinsuffizienz – Stellenwert der biventrikulären Stimulation. Dtsch Med Wochenschr 127:677–681

    Article  PubMed  CAS  Google Scholar 

  • Hoppe UC, Erdmann E, für die Kommission Klinische Kardiologie (2001) Leitlinien zur Therapie der chronischen Herzinsuffizienz. Z Kardiol 90:218–237

    Article  PubMed  CAS  Google Scholar 

  • Hunt SA, Baker DW, Chin MH et al. (2001) ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Tasc Force on practice guidelines Committee to revise the 1995 guidelines for the evaluation and management of heart failure developed in collaboration with the International Society for Heart and Lung Transplantation endorsed by the Heart Failure Society of America. J Am Coll Cardiol 38:2101–2113

    Article  PubMed  CAS  Google Scholar 

  • Kindermann M, Janzen I, Hennen B, Böhm M (2002) Chronische Herzinsuffizienz: Therapie. Dtsch Med Wochenschr 127:1139–1144

    Article  PubMed  CAS  Google Scholar 

  • Linde C, Leclerq C, Rex S et al. (2002) Long-term benefits of biventricular pacing in congestive heart failure: results from the Multisite Stimulation In Cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 40:111–118

    Article  PubMed  Google Scholar 

  • Luchner A, Holmer S, Schunkert H, Riegger GA (2004) Bedeutung der Herzinsuffizienzmarker BNP und NT-proBNP für die Klinik. Dtsch Arztebl 100:A-3314–3321

    Google Scholar 

  • McMurray JJ, Ostergren J, Swedberg K et al. (2003) Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added Trial. Lancet 362:767–771

    Article  PubMed  CAS  Google Scholar 

  • Moss AJ, Zareba W, Hall WJ et al. (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883

    Article  PubMed  Google Scholar 

  • Packer M, Abraham WT (2001) Effect of cardiac resynchronisation on a composite clinical status endpoint in patients with chronic heart failure: results of the MIRACLE trial. Circulation 104:1995

    Google Scholar 

  • Pfeffer MA, Braunwald E, Moye LA et al., on behalf of the SAVE Investigators (1992) Effect of captopril on mortality in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 327:669–677

    Article  PubMed  CAS  Google Scholar 

  • Pfeffer MA, McMurray JJ, Velazquez EJ et al. (2003) for the Valsartan in Acute Myocardial Infarction Trial Investigators Valsartan, captopril or both in myocardial infarction complicated by heart failure, left-ventricular dysfunction, or both. N Engl J Med 349:1893–1906

    Article  PubMed  CAS  Google Scholar 

  • Pitt B, Zannad F, Remme WJ et al., for the Randomized Aldactone Evaluation Study Investigators (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341:709–717

    Article  PubMed  CAS  Google Scholar 

  • Pitt B, Poole-Wilson PA, Segal R et al. (2000) Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomized trial – the Losartan Heart Failure Survival Study ELITE II. Lancet 355:1582–1587

    Article  PubMed  CAS  Google Scholar 

  • Pitt B, Remme WJ, Zannad F, for the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators (2003) Eplerenone, a selective aldosterone blocker, in patients with left-ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309–1321

    Article  PubMed  CAS  Google Scholar 

  • Poole-Wilson PA, Swedberg K, Cleland JG et al. (2003) Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomized controlled trial. Lancet 362:7–13

    Article  PubMed  CAS  Google Scholar 

  • Rathore SS, Wang Y, Krumholz HM (2002) Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 347:1403–1411

    Article  PubMed  CAS  Google Scholar 

  • Rauch H, Motsch J, Bottiger BW (2006) Newer approaches to the pharmacological management of heart failure. Curr Opin Anaesthesiol 19:75–81

    Article  PubMed  Google Scholar 

  • Redfield MM (2004) Understanding »diastolic« heart failure. N Engl J Med 350:1939–1941

    Article  Google Scholar 

  • Schmid FX, Hengstenberg C, Völkel S, Birnbaum D (2004) Chirurgische Therapieoptionen bei schwerer Herzinsuffizienz. Dtsch Arztebl 101:A 429–435

    Google Scholar 

  • Schwinger RHG, Brixius K (2005) Wenn die Myofilamente sensibel werden. Ca2+-Sensitizer zur Therapie der Herzinsuffizienz. Dtsch Med Wochenschr 130: 969–973

    Article  PubMed  CAS  Google Scholar 

  • The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 29: 2388–2442

    Article  Google Scholar 

  • Schwinger RHG (2002) Therapie der Herzinsuffizienz mit ß-Rezeptorenblockern. Dtsch Med Wochenschr 127:682–688

    Article  PubMed  CAS  Google Scholar 

  • The Antiarrhythmics Versus Implantable defibrillators (AVID) investigators (1997) A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337:1576–1583

    Article  Google Scholar 

  • Zannad F, McMurray JJV Krum H et al. (2011) Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms. N Engl J Med 364: 11–21

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chefarzt der Klinik für Anästhesie und Intensivmedizin, Marienhaus Klinikum Bendorf-Neuwied-Waldbreitbach, Friedrich-Ebert-Straße 59, 56564, Neuwied

    Dr. med. Michael Fresenius

  2. Facharzt für Anästhesiologie – ambulante Narkosen –, Max-Reger-Str. 10, 69121, Heidelberg

    Dr. med. Michael Heck

Authors
  1. Dr. med. Michael Fresenius
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. med. Michael Heck
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Fresenius, M., Heck, M. (2011). Herzinsuffizienz. In: Repetitorium Intensivmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16879-6_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-16879-6_31

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-16878-9

  • Online ISBN: 978-3-642-16879-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation